| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.1M | +14.5% |
| SG&A Expense | $5.0M | +13.1% |
| Operating Income | -$9.1M | -13.7% |
| Income Tax | $0 | — |
| Net Income | -$8.9M | +40.7% |
| EPS (Basic) | -$23.95 | +72.7% |
| EPS (Diluted) | -$23.95 | +72.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | +64.6% |
| Current Assets | $10.8M | +64.7% |
| Total Assets | $11.6M | +74.9% |
| Current Liabilities | $2.0M | +4.4% |
| Total Liabilities | $2.7M | +42.2% |
| Stockholders' Equity | $8.9M | +88.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.3M | +54.9% |
| Capital Expenditures | $19K | +0.0% |
| Investing Cash Flow | -$19K | +0.0% |
| Financing Cash Flow | $12.5M | -2.9% |
| Free Cash Flow | -$8.3M | +54.8% |